In recent times, research has unveiled their capacity to inhibit acetylcholinesterase (AChE) and/or butyrylcholinesterase (BChE), which are enzymes that play pivotal roles in neurodegenerative disorders such as Alzheimer’s disease [2,3]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.